본문으로 건너뛰기
← 뒤로

Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study.

EJNMMI research 2022 Vol.12(1) p. 45

Liu Y, Wang Y, Zhang W

📝 환자 설명용 한 줄

[BACKGROUND] Differentiated thyroid carcinoma (DTC) originates from abnormal follicular cells and accounts for approximately 90-95% of thyroid malignancies.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 95% CI 2.388-22.698

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Liu Y, Wang Y, Zhang W (2022). Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study.. EJNMMI research, 12(1), 45. https://doi.org/10.1186/s13550-022-00917-8
MLA Liu Y, et al.. "Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study.." EJNMMI research, vol. 12, no. 1, 2022, pp. 45.
PMID 35904608

Abstract

[BACKGROUND] Differentiated thyroid carcinoma (DTC) originates from abnormal follicular cells and accounts for approximately 90-95% of thyroid malignancies. The diagnosis of radioiodine refractory DTC (RR-DTC) is based on clinical evolution and iodine uptake characteristics rather than pathological characteristics. Thus, it takes a long time to become apparent, and the definition of RR-DTC covers multiple aspects. We aimed to analyze the clinical and molecular imaging characteristics of patients with RR-DTC and identify independent predictors to develop an RR-DTC scoring system and a simple nomogram for predicting the probability of RR-DTC. We reviewed the data of 404 patients with metastatic DTC who underwent both post-RAI WB therapy scintigraphy and F-fluorodeoxyglucose (F-FDG) positron emission tomography/computed tomography. Data on the clinical features and molecular characteristics of RR-DTC and non-RR-DTC cases were obtained from medical records. We screened for predictors using univariate analyses, obtained independent predictors through multivariate analyses, and then established a scoring system and a simple nomogram for predicting RR-DTC according to the corresponding odds ratio (OR) values.

[RESULTS] Diagnosis at age ≥ 48 years (OR, 1.037; 95% confidence interval [CI], 1.007-1.069), recurrence between the operation and iodine-131 treatment (OR, 7.362; 95% CI 2.388-22.698), uptake of F-FDG (OR, 39.534; 95% CI 18.590-84.076), and the metastasis site (OR, 4.365; 95% CI 1.593-11.965) were highly independently associated with RR-DTC. We established a scoring system for predicting RR-DTC, showing that the area under the receiver operating characteristic curve (AUC) with a cutoff value of 10 points (AUC = 0.898) had a higher discernibility than any other single independent predictor. The risk factors of RR-DTC in nomogram modeling include diagnosis at age ≥ 48 years, recurrence between the operation and iodine-131 treatment, uptake of F-FDG, and the site of metastasis. The concordance index (c-Index) of the nomogram was 0.9.

[CONCLUSIONS] We demonstrated that a predictive model based on four factors has a good ability to predict RR-DTC. An index score ≥ 10 points was found to be the optimal index point for predicting RR-DTC. Moreover, this nomogram model has good predictive ability and stability. This model may help establish an active surveillance or appropriate treatment strategy for RR-DTC cases.

같은 제1저자의 인용 많은 논문 (5)